Bioventus Inc. (BVS) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2019: $90.94M2020: $87.64M2021: $128.19M2022: $181.04M2023: $184.15M2024: $185.05M2025: $179.93M$179.93M
2019Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$179.93M-2.8%
2024$185.05M+0.5%
2023$184.15M+1.7%
2022$181.04M+41.2%
2021$128.19M+46.3%
2020$87.64M-3.6%
2019$90.94M